Public health emergencies, such as an Ebola disease outbreak, provide a complex and challenging environment for the evaluation of candidate vaccines. Here, we outline the need for flexible and responsive vaccine trial designs to be used in public health emergencies, and we summarize recommendations for their use in this setting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613811 | PMC |
http://dx.doi.org/10.1126/scitranslmed.aat0360 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!